These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36094777)

  • 21. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
    J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
    Shimamura T; Hasegawa N; Kubota N
    Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Kishida H; Okubo A
    J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
    Shimoyama H; Kuwano Y; Sei Y
    Med Mycol J; 2019; 60(4):95-100. PubMed ID: 31787733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efinaconazole Topical Solution, 10%: Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson BC; Caldwell BD
    J Am Podiatr Med Assoc; 2015 Apr; ():. PubMed ID: 25867759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.
    Iwata A; Watanabe Y; Kumagai N; Katafuchi-Nagashima M; Sugiura K; Pillai R; Tatsumi Y
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4920-2. PubMed ID: 24867968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
    Saunders J; Maki K; Koski R; Nybo SE
    J Pharm Pract; 2017 Dec; 30(6):621-630. PubMed ID: 27488125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination
    Halvaee S; Daie-Ghazvini R; Hashemi SJ; Khodavaisy S; Rahimi-Foroushani A; Bakhshi H; Rafat Z; Ardi P; Abastabar M; Zareei M; Borjian-Boroujeni Z; Kamali Sarvestani H
    Front Cell Infect Microbiol; 2021; 11():693522. PubMed ID: 34336717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimycotic therapy of Tinea unguium and other onychomycoses].
    Stock I
    Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
    Jo W; Glynn M; Nejishima H; Sanada H; Minowa K; Calvarese B; Senda H; Pillai R; Mutter L
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):242-53. PubMed ID: 25038564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
    Gupta AK; Venkataraman M; Shear NH; Piguet V
    Dermatol Ther; 2020 Jul; 33(4):e13613. PubMed ID: 32418289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
    Scher RK; Nakamura N; Tavakkol A
    Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.